The investigation of the role of interleukin (IL)-17 in COPD and asthma Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005
Targeting the interleukin pathway in the treatment of asthma Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient Year: 2015
Interleukin 4 receptor, interleukin 17 and clinical presentation of chronic EAA Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013
Characterization of severe asthma in children over 6 years Source: International Congress 2017 – Diagnostic tools in paediatric asthma Year: 2017
Haplotype analysis of interleukin 18 (IL-18) gene in Czech patients with allergic asthma Source: Annual Congress 2008 - Asthma: mechanisms and treatment Year: 2008
Interleukin 18 in the sputum of healthy and COPD smokers: evidence of implication in airway and systemic inflammation Source: Eur Respir J 2007; 30: Suppl. 51, 749s Year: 2007
Interleukin 18: implication in airway inflammation and pulmonary function in healthy and bronchitis type COPD smokers Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008
Profile of selected cytokines in serum and in BAL-fluid in patients with cryptogenic organising pneumonia before and after 3 months of calrithromycin treatment Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010
Efficacy of montelukast in patients aged 2 to 5 years with mild asthma Source: Eur Respir J 2004; 24: Suppl. 48, 377s Year: 2004
Measurement of tumor necrosis factor (TNF)α, leukotriene B4 (LTB4), and interleukin 8 (IL8) in the exhaled breath condensate (EBC) in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007
Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006
Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013
Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
Formoterol in acute asthma in children 6-14 years old Source: Eur Respir J 2003; 22: Suppl. 45, 133s Year: 2003
Serum Interleukin (IL)-6 levels in patients with severe asthma disease is associated with blood eosinophilia Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020
Interleukin-10 (IL-10) level in sputum of asthmatic patients during exacerbation and after treatment Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Changes of TNF-a level in bronchoalveolar fluid of patients with chronic obstructive pulmonary disease before and after the 30 days treatment with tiotropium bromide Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015
Release of IL-1b, IL-6 and TNF-a after pulmonary rehabilitation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Physiological response to exercise performance Year: 2008
Serum interleukin 18 as a monitoring marker of long clinical course of pulmonary sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 711s Year: 2004
The haplotypes of interleukin 10 but not that of tumour necrosis factor alpha/lymphotoxin alpha and interleukin 1 cluster are associated with susceptibility for COPD Source: Eur Respir J 2005; 26: Suppl. 49, 105s Year: 2005